Home CURRENT AFFAIRS Covid update: India records 26 per cent of the total global cases...

Covid update: India records 26 per cent of the total global cases last week after surge in testing process

0

India registered 59,696 fresh coronavirus cases in the past 24 hours, taking its total tally to 3,164,881. With 854 casualties recorded, the nation’s total death toll has reached 58,546. The recoveries have crossed 23 lakhs and are more than three times the active number of cases in the country, while the fatality rate has also maintained a downward trajectory as it further dropped to 1. 85 per cent, the health ministry said.

India has also ramped up its testing as Covid-tests per million surged to 26,016 while total tests have risen to a whopping number of 3.5 crore.

The health ministry mentioned that key factor in India’s battle against has been early identification of cases by timely and aggressive testing.

“India has tested more than 3.5 crore people for COVID-19 so far, resolutely following its ‘Test Track Treat’ strategy,” the MoHFW tweeted.

As per the latest covid-19 reports, India has recorded 26 per cent of the total global cases, crossing the quarter mark for the first time.

The worst-hit state of the country, Maharashtra, showed a slight improvement as it reported 212 fatalities, which was the lowest in the past 34 days. Mumbai registered 20 deaths, its lowest number in 105 days, since May 11.

With the fresh additions, the total death toll of the state currently stands 22,465 and that of Mumbai is 7,442.

In other coronavirus related news, researchers in Hong Kong on Monday found out first confirmed case worldwide of Covid-19 reinfection, raising questions about the sustainability of immunity. The 33-year-old IT worker was discharged from a hospital in April. He has been re-infected with the virus after returning from Spain earlier this month.

Meanwhile, after Russia, China has allegedly started vaccinating its people without completing all the mandatory tests of the vaccine candidate. The said vaccine, which is being developed by state-owned Sinopharm, is currently undergoing phase-3 trials in United Arab Emirates. However, Chinese health officials have claimed that it was already being tested on people since July 22 under emergency use authorisation.

Exit mobile version